Discover
CABA
Cabaletta Bio, Inc.
1.91
42 x 1.47
35 x 20.00
bid
ask
-
0.06
3.05%
03:11 PM
timesize
| Ytd | -12.79% | |
| 1y | -20.75% |
1.87
day range
1.97
1.83
52 week range
4.23
| Open | 1.96 | Prev Close | 1.97 | Low | 1.87 | High | 1.97 | Mkt Cap | 323.83M |
| Vol | 3.47M | Avg Vol | 4.67M | EPS | -1.51 | P/E | N/A | Forward P/E | -0.98 |
| Beta | 3.48 | Short Ratio | 4.26 | Inst. Own | 100.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 2.72 | 200-d Avg | 2.91 | 1yr Est | 22.22 |
| Income Statement | |||
| Operating Expenses | 52.02M | ||
| Research and Development Expense | 44.43M | ||
| Selling, General and Administrative Expense | 7.59M | ||
| Operating Income | -52.02M | ||
| Interest Expense | 517.00K | ||
| Net Income | -51.02M | ||
| Net Income Common Stock | -51.02M | ||
| Net Income Common Stock (USD) | -51.02M | ||
| Consolidated Income | -51.02M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -50.50M | ||
| Earning Before Interest & Taxes (USD) | -50.50M | ||
| Weighted Average Shares | 151.16M | ||
| Weighted Average Shares Diluted | 151.16M | ||
| Balance Sheet | |||
| Cash and Equivalents | 225.10M | ||
| Cash and Equivalents (USD) | 225.10M | ||
| Current Assets | 231.03M | ||
| Property, Plant & Equipment Net | 19.49M | ||
| Total Assets | 256.73M | ||
| Debt Current | 19.49M | ||
| Total Debt | 25.71M | ||
| Current Liabilities | 39.91M | ||
| Debt Non-Current | 6.23M | ||
| Total Liabilities | 46.14M | ||
| Accumulated Retained Earnings (Deficit) | -611.49M | ||
| Shareholders Equity | 210.59M | ||
| Shareholders Equity (USD) | 210.59M | ||
| Assets Non-Current | 25.70M | ||
| Total Debt (USD) | 25.71M | ||
| Liabilities Non-Current | 6.23M | ||
| Trade and Non-Trade Payables | 5.81M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.36M | ||
| Net Cash Flow from Financing | 149.99M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 108.47M | ||
| Issuance (Purchase) of Equity Shares | 152.81M | ||
| Issuance (Repayment) of Debt Securities | -2.82M | ||
| Net Cash Flow from Operations | -41.51M | ||
| Effect of Exchange Rate Changes on Cash | -7.00K | ||
| Share Based Compensation | 5.50M | ||